Ibrutinib protects T cells in patients with CLL from proliferation-induced senescence.

Davis, Joanne E; Sharpe, Chia; Mason, Kylie; Tam, Constantine S; Koldej, Rachel M; Ritchie, David S

Davis, Joanne E; Sharpe, Chia; Mason, Kylie; Tam, Constantine S; Koldej, Rachel M; Ritchie, David S.

Afiliación

Davis JE; ACRF Translational Research Laboratory, Royal Melbourne Hospital, Melbourne, Australia.
Sharpe C; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.
Mason K; ACRF Translational Research Laboratory, Royal Melbourne Hospital, Melbourne, Australia.
Tam CS; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.
Koldej RM; ACRF Translational Research Laboratory, Royal Melbourne Hospital, Melbourne, Australia.
Ritchie DS; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.

J Transl Med ; 19(1): 473, 2021 11 22.

Article en En | MEDLINE | ID: mdl-34809665

Asunto(s)

Leucemia Linfocítica Crónica de Células B; Adenina/análogos & derivados; Proliferación Celular; Humanos; Leucemia Linfocítica Crónica de Células B/tratamiento farmacológico; Leucocitos Mononucleares; Piperidinas; Inhibidores de Proteínas Quinasas; Linfocitos T

Palabras clave

Bruton's tyrosine kinase inhibitors; Chronic Lymphocytic Leukaemia; Proliferation; Senescence; T cells

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Idioma: En Revista: J Transl Med Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google